Darius Lakdawalla

Names

Identifer

Contact

Affiliations

• University of Southern California / Leonard D. Schaeffer Center for Health Policy and Economics (weight: 98%)
  • EDIRC entry
  • location:
• University of Southern California / Sol Price School of Public Policy (weight: 1%)
  • EDIRC entry
  • location:

Research profile

author of:

• The Rise in Old-Age Longevity and the Market for Long-Term Care (RePEc:aea:aecrev:v:92:y:2002:i:1:p:295-306)
  by Darius Lakdawalla & Tomas Philipson
• Welfare-Enhancing Technological Change and the Growth of Obesity (RePEc:aea:aecrev:v:95:y:2005:i:2:p:253-257)
  by Darius Lakdawalla & Tomas Philipson & Jay Bhattacharya
• Economics of the Pharmaceutical Industry (RePEc:aea:jeclit:v:56:y:2018:i:2:p:397-449)
  by Darius N. Lakdawalla
• Geographic Variation in Health Care: The Role of Private Markets (RePEc:bin:bpeajo:v:41:y:2010:i:2010-01:p:325-361)
  by Tomas J. Philipson & Seth A. Seabury & Lee M. Lockwood & Dana P. Goldman & Darius N. Lakdawalla
• How Does Health Insurance Affect Workers’ Compensation Filing? (RePEc:bla:ecinqu:v:45:y:2007:i:2:p:286-303)
  by Darius N Lakdawalla & Robert T Reville & Seth A Seabury
• Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk Transfer (RePEc:bla:jrinsu:v:79:y:2012:i:2:p:449-476)
  by Darius Lakdawalla & George Zanjani
• Insurers’ Negotiating Leverage and the External Effects of Medicare Part D (RePEc:bos:wpaper:wp2011-065)
  by Wesley Yin & Darius Lakdawalla
• A Theory of Health Disparities and Medical Technology (RePEc:bpj:bejeap:v:contributions.4:y:2005:i:1:n:8)
  by Goldman Dana P & Lakdawalla Darius N.
• Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall (RePEc:bpj:evoice:v:10:y:2013:i:1:p:39-43:n:1)
  by Goldman Dana P. & Leive Adam & Lakdawalla Darius
• Are Biopharmaceutical Budget Caps Good Public Policy? (RePEc:bpj:evoice:v:13:y:2016:i:1:p:27-42:n:1)
  by Goldman Dana P. & Lakdawalla Darius N. & Baumgardner James R. & Linthicum Mark T.
• Can the ACA Improve Population Health? (RePEc:bpj:evoice:v:7:y:2010:i:5:n:4)
  by Goldman Dana P & Lakdawalla Darius N
• The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 (RePEc:bpj:fhecpo:v:13:y:2010:i:2:n:1)
  by Sun Eric & Jena Anupam B & Lakdawalla Darius & Reyes Carolina & Philipson Tomas J & Goldman Dana
• The Value of Diagnostic Testing in Personalized Medicine (RePEc:bpj:fhecpo:v:16:y:2013:i:2:p:121-133:n:6)
  by Goldman Dana P. & Lakdawalla Darius & Sood Neeraj & Gupta Charu & Vasudeva Eshan & Trakas Kostas & Riley Ralph & Agus David & Jena Anupam B. & Philipson Tomas J.
• A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies (RePEc:bpj:fhecpo:v:17:y:2014:i:1:p:32:n:5)
  by Stevens Warren & Philipson Tomas & Wu Yanyu & Chen Connie & Lakdawalla Darius
• Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants (RePEc:bpj:fhecpo:v:17:y:2014:i:2:p:16:n:4)
  by Seabury Seth A. & Lakdawalla Darius N. & Goldman Dana P. & Walter Deborah & Hayes John & Gustafson Thomas & Shrestha Anshu
• Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital? (RePEc:bpj:fhecpo:v:17:y:2014:i:2:p:21:n:3)
  by Lakdawalla Darius N. & Snider Julia Thornton & Linthicum Mark T. & Perlroth Daniella J. & LaVallee Chris & Philipson Tomas J. & Partridge Jamie S. & Wischmeyer Paul E.
• Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets (RePEc:bpj:fhecpo:v:18:y:2015:i:1:p:65-74:n:4)
  by Chou Jacquelyn W. & Lakdawalla Darius N. & Vanderpuye-Orgle Jacqueline
• Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection (RePEc:bpj:fhecpo:v:19:y:2016:i:1:p:141-156:n:6)
  by Seabury Seth A. & Goldman Dana P. & Lakdawalla Darius N. & Gupta Charu N. & Khan Zeba M. & Chandra Amitabh & Philipson Tomas J.
• The Social Value of Improvement in Activities of Daily Living among the Advanced Parkinson’s Disease Population (RePEc:bpj:fhecpo:v:23:y:2020:i:2:p:1-23:n:1)
  by Sullivan Jeffrey & Shih Tiffany M. & van Eijndhoven Emma & Lakdawalla Darius N. & Benner Jennifer & Jalundhwala Yash J. & Zadikoff Cindy & Marshall Thomas S. & Sail Kavita R.
• Public Financing and the Market for Long-Term Care (RePEc:bpj:fhecpo:v:4:y:2001:n:4)
  by Lakdawalla Darius & Philipson Thomas
• Disability Forecasts and Future Medicare Costs (RePEc:bpj:fhecpo:v:7:y:2004:n:4)
  by Bhattacharya Jayanta & Cutler David M. & Goldman Dana P. & Hurd Michael D. & Joyce Geoffrey F. & Lakdawalla Darius N. & Panis Constantijn W. A. & Shang Baoping
• The Labor Market Value of Health Improvements (RePEc:bpj:fhecpo:v:biomedical_research:y:2006:n:2)
  by Bhattacharya Jay & Lakdawalla Darius Noshir
• The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation (RePEc:cup:jbcoan:v:14:y:2023:i:1:p:44-67_4)
  by Lakdawalla, Darius N. & Phelps, Charles E.
• Unknown item RePEc:dem:demres:v:8:y:2003:i:10 (article)
• Social insurance and the design of innovation incentives (RePEc:eee:ecolet:v:85:y:2004:i:1:p:57-61)
  by Lakdawalla, Darius & Sood, Neeraj
• The growth of obesity and technological change (RePEc:eee:ehbiol:v:7:y:2009:i:3:p:283-293)
  by Lakdawalla, Darius & Philipson, Tomas
• Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products (RePEc:eee:heachp:2-825)
  by Goldman, Dana & Lakdawalla, Darius
• The welfare effects of medical malpractice liability (RePEc:eee:irlaec:v:32:y:2012:i:4:p:356-369)
  by Lakdawalla, Darius N. & Seabury, Seth A.
• An economic evaluation of the war on cancer (RePEc:eee:jhecon:v:29:y:2010:i:3:p:333-346)
  by Lakdawalla, Darius N. & Sun, Eric C. & Jena, Anupam B. & Reyes, Carolina M. & Goldman, Dana P. & Philipson, Tomas J.
• The value of medical and pharmaceutical interventions for reducing obesity (RePEc:eee:jhecon:v:31:y:2012:i:4:p:630-643)
  by Michaud, Pierre-Carl & Goldman, Dana P. & Lakdawalla, Darius N. & Zheng, Yuhui & Gailey, Adam H.
• Pharmaceutical advertising and Medicare Part D (RePEc:eee:jhecon:v:32:y:2013:i:6:p:1356-1367)
  by Lakdawalla, Darius & Sood, Neeraj & Gu, Qian
• Are investments in disease prevention complements? The case of statins and health behaviors (RePEc:eee:jhecon:v:36:y:2014:i:c:p:151-163)
  by Kaestner, Robert & Darden, Michael & Lakdawalla, Darius
• The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions (RePEc:eee:jhecon:v:51:y:2017:i:c:p:1-12)
  by Bognar, Katalin & Romley, John A. & Bae, Jay P. & Murray, James & Chou, Jacquelyn W. & Lakdawalla, Darius N.
• Healing the poor: The influence of patient socioeconomic status on physician supply responses (RePEc:eee:jhecon:v:64:y:2019:i:c:p:43-54)
  by Chen, Alice & Lakdawalla, Darius N.
• Health technology assessment with risk aversion in health (RePEc:eee:jhecon:v:72:y:2020:i:c:s0167629619309208)
  by Lakdawalla, Darius N. & Phelps, Charles E.
• Health insurance as a two-part pricing contract (RePEc:eee:pubeco:v:102:y:2013:i:c:p:1-12)
  by Lakdawalla, Darius & Sood, Neeraj
• The insurance value of medical innovation (RePEc:eee:pubeco:v:145:y:2017:i:c:p:94-102)
  by Lakdawalla, Darius & Malani, Anup & Reif, Julian
• Prescription drug advertising and drug utilization: The role of Medicare Part D (RePEc:eee:pubeco:v:221:y:2023:i:c:s0047272723000427)
  by Alpert, Abby & Lakdawalla, Darius & Sood, Neeraj
• Insurance, self-protection, and the economics of terrorism (RePEc:eee:pubeco:v:89:y:2005:i:9-10:p:1891-1905)
  by Lakdawalla, Darius & Zanjani, George
• Does Medicare benefit the poor? (RePEc:eee:pubeco:v:90:y:2006:i:1-2:p:277-292)
  by Bhattacharya, Jay & Lakdawalla, Darius
• The nonprofit sector and industry performance (RePEc:eee:pubeco:v:90:y:2006:i:8-9:p:1681-1698)
  by Lakdawalla, Darius & Philipson, Tomas
• Innovation and the welfare effects of public drug insurance (RePEc:eee:pubeco:v:93:y:2009:i:3-4:p:541-548)
  by Lakdawalla, Darius & Sood, Neeraj
• Differences in health between Americans and Western Europeans: Effects on longevity and public finance (RePEc:eee:socmed:v:73:y:2011:i:2:p:254-263)
  by Michaud, Pierre-Carl & Goldman, Dana & Lakdawalla, Darius & Gailey, Adam & Zheng, Yuhui
• Economics of Obesity (RePEc:elg:eechap:14021_7)
  by Peter J. Huckfeldt & Darius N. Lakdawalla & Tomas J. Philipson
• Economics of Obesity (RePEc:elg:eechap:3572_7)
  by Darius Lakdawalla & Tomas J. Philipson
• Patents, innovation, and the welfare effects of Medicare Part D (RePEc:eme:aheszz:s0731-2199(2010)0000022017)
  by Adam Gailey & Darius Lakdawalla & Neeraj Sood
• Nonprofit Production (RePEc:fth:chiprc:97-8)
  by Tomas Philipson & Darius Lakdawalla
• The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination (RePEc:har:wpaper:0203)
  by Darius Lakdawalla & Tomas Philipson
• Aging and the Growth of Long-Term Care (RePEc:har:wpaper:9909)
  by Darius Lakdawalla & Tomas Philipson
• Effects of expanding health screening on treatment – What should we expect? What can we learn? (RePEc:hka:wpaper:2018-014)
  by Rebecca Myerson & Darius Lakdawalla & Lisandro D. Colantonio & Monika Safford & David Meltzer
• Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? (RePEc:hka:wpaper:2019-054)
  by Rebecca Myerson & Reginald Tucker-Seeley & Dana Goldman & Darius Lakdawalla
• Understanding the Economic Consequences of Shifting Trends in Population Health (RePEc:iza:izadps:dp4366)
  by Michaud, Pierre-Carl & Goldman, Dana P. & Lakdawalla, Darius N. & Zheng, Yuhui & Gailey, Adam H.
• International Differences in Longevity and Health and Their Economic Consequences (RePEc:iza:izadps:dp4367)
  by Michaud, Pierre-Carl & Goldman, Dana P. & Lakdawalla, Darius N. & Zheng, Yuhui & Gailey, Adam H.
• Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data (RePEc:lvl:lacicr:1038)
  by Pierre-Carl Michaud & Darius Lakdawalla & Dana Goldman & Neeraj Sood & Ze Cong
• The Value of Medican and Pharmaceutical Interventions for Reducing Obesity (RePEc:lvl:lacicr:1109)
  by Pierre-Carl Michaud & Dana Goldman & Darius Lakdawalla & Yuhui Zhen & Adam H. Gailey
• International Differences in Longevity and Health and their Economic Consequences (RePEc:mcm:sedapp:254)
  by P.-C. Michaud & D. Goldman & D. Lakdawalla & A. Gailey & Y. Zheng
• Understanding the Economic Consequences of Shifting Trends in Population Health (RePEc:mcm:sedapp:255)
  by P.-C. Michaud & D. Goldman & D. Lakdawalla & Y. Zheng & A. Gailey
• Economic Instruments for Obesity Prevention: Results of a Scoping Review and Modified Delphi Survey (RePEc:mos:moswps:2011-31)
  by Guy E.J. Faulkner & Paul Grootendorst & Van Hai Nguyen & Tatiana Andreyeva & Kelly Arbour-Nicitopoulos & Chris Auld & Sean B. Cash & John Cawley & Peter Donnelly & Adam Drewnowski & Laurette Dubé & R
• Food Prices and the Dynamics of Body Weight (RePEc:nbr:nberch:11817)
  by Dana Goldman & Darius Lakdawalla & Yuhui Zheng
• Medical Care Output and Productivity in the Nonprofit Sector (RePEc:nbr:nberch:7627)
  by Tomas Philipson & Darius Lakdawalla
• Public Financing and the Market for Long-Term Care (RePEc:nbr:nberch:9852)
  by Darius Lakdawalla & Tomas Philipson
• Disability Forecasts and Future Medicare Costs (RePEc:nbr:nberch:9870)
  by Jayanta Bhattacharya & David M. Cutler & Dana P. Goldman & Michael D. Hurd & Geoffrey F. Joyce & Darius N. Lakdawalla & Constantijn W. A. Panis
• Time-Inconsistency and Welfare (RePEc:nbr:nberwo:10345)
  by Jay Bhattacharya & Darius Lakdawalla
• HIV Breakthroughs and Risk Sexual Behavior (RePEc:nbr:nberwo:10516)
  by Dana Goldman & Darius Lakdawalla & Neeraj Sood
• Insurance and Innovation in Health Care Markets (RePEc:nbr:nberwo:11602)
  by Darius Lakdawalla & Neeraj Sood
• Intellectual Property and Marketing (RePEc:nbr:nberwo:12577)
  by Darius Lakdawalla & Tomas Philipson & Y. Richard Wang
• Optimal Liability for Terrorism (RePEc:nbr:nberwo:12578)
  by Darius Lakdawalla & Eric Talley
• Health Insurance as a Two-Part Pricing Contract (RePEc:nbr:nberwo:12681)
  by Darius Lakdawalla & Neeraj Sood
• Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk-Transfer (RePEc:nbr:nberwo:12742)
  by Darius Lakdawalla & George Zanjani
• The Welfare Effects of Public Drug Insurance (RePEc:nbr:nberwo:13501)
  by Darius Lakdawalla & Neeraj Sood
• Food Prices and the Dynamics of Body Weight (RePEc:nbr:nberwo:15096)
  by Dana Goldman & Darius Lakdawalla & Yuhui Zheng
• Understanding the Economic Consequences of Shifting Trends in Population Health (RePEc:nbr:nberwo:15231)
  by Pierre-Carl Michaud & Dana Goldman & Darius Lakdawalla & Yuhui Zheng & Adam Gailey
• International Differences in Longevity and Health and their Economic Consequences (RePEc:nbr:nberwo:15235)
  by Pierre-Carl Michaud & Dana Goldman & Darius Lakdawalla & Adam Gailey & Yuhui Zheng
• Insurer Bargaining and Negotiated Drug Prices in Medicare Part D (RePEc:nbr:nberwo:15330)
  by Darius Lakdawalla & Wesley Yin
• The Welfare Effects of Medical Malpractice Liability (RePEc:nbr:nberwo:15383)
  by Darius N. Lakdawalla & Seth A. Seabury
• An Economic Evaluation of the War on Cancer (RePEc:nbr:nberwo:15574)
  by Eric C. Sun & Anupam B. Jena & Darius N. Lakdawalla & Carolina M. Reyes & Tomas J. Philipson & Dana P. Goldman
• Insurers' Negotiating Leverage and the External Effects of Medicare Part D (RePEc:nbr:nberwo:16251)
  by Darius N. Lakdawalla & Wesley Yin
• Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market (RePEc:nbr:nberwo:20005)
  by Eric Helland & Darius N. Lakdawalla & Anup Malani & Seth A. Seabury
• The Insurance Value of Medical Innovation (RePEc:nbr:nberwo:21015)
  by Darius Lakdawalla & Anup Malani & Julian Reif
• Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D (RePEc:nbr:nberwo:21714)
  by Abby Alpert & Darius Lakdawalla & Neeraj Sood
• Healing the Poor: The Influence of Patient Socioeconomic Status on Physician Supply Responses (RePEc:nbr:nberwo:21930)
  by Alice Chen & Darius N. Lakdawalla
• Effects of Expanding Health Screening on Treatment - What Should We Expect? What Can We Learn? (RePEc:nbr:nberwo:24347)
  by Rebecca Mary Myerson & Darius Lakdawalla & Lisandro D. Colantonio & Monika Safford & David Meltzer
• Mortality Risk, Insurance, and the Value of Life (RePEc:nbr:nberwo:25055)
  by Daniel Bauer & Darius Lakdawalla & Julian Reif
• Evaluation of Medical Technologies with Uncertain Benefits (RePEc:nbr:nberwo:26058)
  by Darius N. Lakdawalla & Charles E. Phelps
• Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? (RePEc:nbr:nberwo:26292)
  by Rebecca Mary Myerson & Reginald Tucker-Seeley & Dana Goldman & Darius N. Lakdawalla
• Vaccine Allocation Priorities Using Disease Surveillance and Economic Data (RePEc:nbr:nberwo:29682)
  by Anup Malani & Satej Soman & Sabareesh Ramachandran & Alice Chen & Darius N. Lakdawalla
• Risk Preferences Over Health: Empirical Estimates and Implications for Healthcare Decision-Making (RePEc:nbr:nberwo:31524)
  by Karen Mulligan & Drishti Baid & Jason N. Doctor & Charles E. Phelps & Darius N. Lakdawalla
• Nonprofit Production and Competition (RePEc:nbr:nberwo:6377)
  by Darius Lakdawalla & Tomas Philipson
• The Rise in Old Age Longevity and the Market for Long-Term Care (RePEc:nbr:nberwo:6547)
  by Darius Lakdawalla & Tomas Philipson
• Aging and the Growth of Long-Term Care (RePEc:nbr:nberwo:6980)
  by Darius Lakdawalla & Tomas Philipson
• Are the Young Becoming More Disabled? (RePEc:nbr:nberwo:8247)
  by Darius Lakdawalla & Dana Goldman & Jay Bhattacharya
• The Declining Quality of Teachers (RePEc:nbr:nberwo:8263)
  by Darius Lakdawalla
• Understanding Health Disparities Across Education Groups (RePEc:nbr:nberwo:8328)
  by Dana Goldman & Darius Lakdawalla
• The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination (RePEc:nbr:nberwo:8946)
  by Darius Lakdawalla & Tomas Philipson
• Insurance, Self-Protection, and the Economics of Terrorism (RePEc:nbr:nberwo:9215)
  by Darius Lakdawalla & George Zanjani
• Does Medicare Benefit the Poor? New Answers to an Old Question (RePEc:nbr:nberwo:9280)
  by Jay Bhattacharya & Darius Lakdawalla
• The Fiscal Consequences of Trends in Population Health (RePEc:ntj:journl:v:63:y:2010:i:2:p:307-30)
  by Goldman, Dana & Michaud, Pierre-Carl & Lakdawalla, Darius & Zheng, Yuhui & Gailey, Adam & Vaynman, Igor
• Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market
  [“An Economic Analysis of Mary Carter Settlement Agreements,”] (RePEc:oup:jleorg:v:36:y:2020:i:3:p:598-632.)
  by Eric Helland & Darius Lakdawalla & Anup Malani & Seth A Seabury
• HIV Breakthroughs and Risky Sexual Behavior (RePEc:oup:qjecon:v:121:y:2006:i:3:p:1063-1102.)
  by Darius Lakdawalla & Neeraj Sood & Dana Goldman
• The economics of alternative payment models for pharmaceuticals (RePEc:spr:eujhec:v:22:y:2021:i:4:d:10.1007_s10198-021-01274-4)
  by Jakub P. Hlávka & Jeffrey C. Yu & Dana P. Goldman & Darius N. Lakdawalla
• A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE) (RePEc:spr:eujhec:v:23:y:2022:i:3:d:10.1007_s10198-021-01367-0)
  by Darius N. Lakdawalla & Charles E. Phelps
• A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis (RePEc:spr:pharme:v:37:y:2019:i:6:d:10.1007_s40273-018-00765-2)
  by Devin Incerti & Jeffrey R. Curtis & Jason Shafrin & Darius N. Lakdawalla & Jeroen P. Jansen
• How Does Terrorism Risk Vary Across Space And Time? An Analysis Based On The Israeli Experience (RePEc:taf:defpea:v:18:y:2007:i:2:p:113-131)
  by Claude Berrebi & Darius Lakdawalla
• Insurers’ Negotiating Leverage and the External Effects of Medicare Part D (RePEc:tpr:restat:v:97:y:2015:i:2:p:314-331)
  by Darius Lakdawalla & Wesley Yin
• Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets (RePEc:ucp:jlawec:doi:10.1086/663345)
  by Darius Lakdawalla & Tomas Philipson
• The Economics of Teacher Quality (RePEc:ucp:jlawec:y:2006:v:49:i:1:p:285-329)
  by Lakdawalla, Darius
• Labor Supply and Weight (RePEc:uwp:jhriss:v:42:y:2007:i1:p85-116)
  by Darius Lakdawalla & Tomas Philipson
• Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA (RePEc:wly:hlthec:v:19:y:2010:i:10:p:1109-1116)
  by Dana Goldman & Darius Lakdawalla & Tomas J. Philipson & Wesley Yin
• Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA (RePEc:wly:hlthec:v:19:y:2010:i:12:p:1510-1510)
  by Dana Goldman & Darius Lakdawalla & Tomas J. Philipson & Wesley Yin
• Predicting quantity and quality of life with the Future Elderly Model (RePEc:wly:hlthec:v:30:y:2021:i:s1:p:52-79)
  by Duncan Ermini Leaf & Bryan Tysinger & Dana P. Goldman & Darius N. Lakdawalla
• Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? (RePEc:wly:jpamgt:v:39:y:2020:i:3:p:577-604)
  by Rebecca M. Myerson & Reginald D. Tucker‐Seeley & Dana P. Goldman & Darius N. Lakdawalla
• The Rise in Old Age Longevity and the Market for Long-Term Care (RePEc:zbw:cbscwp:146)
  by Philipson, Tomas J. & Lakdawalla, Darius
• The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination (RePEc:zbw:cbscwp:174)
  by Lakdawalla, Darius & Philipson, Tomas J.
• Intellectual Property and Marketing (RePEc:zbw:cbscwp:216)
  by Philipson, Tomas J. & Lakdawalla, Darius